JPRN-UMIN000015959招募中未知
A study of clinical usefulness and safety of enteral nutrition containing pectin. - A study of clinical usefulness and safety of enteral nutrition containing pectin.
Japan Society for Parenteral and Enteral Nutiroin0 个研究点目标入组 200 人开始时间: 2015年2月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with diarrhea the day before 2.Patients treated with the disable drug and REF-P1 3.Patients undergone with total or subtotal gastrectomy 4.Patients treated with the chemotherapy 5.Patients with the ileus 6.Patients with electrolyte imbalance 7.Patients with severe liver dysfunction or severe kidney dysfunction 8.Patiens with glucose metabolism disorder such as diabetes or inborn error of amino acid metabolism 9.Patients with infectious enteritis 10.Patients with other conditions not suitable for this study
研究者
相似试验
招募中
不适用
Clinical evaluation of PET probe [18F]SMBT-1Alzheimer's disease (AD), Progressive Supranulcear Palsy (PSP)JPRN-jRCTs021200019Tashiro Manabu24
已完成
不适用
Investigation for clinical efficacy and safety of ipragliflozin 50mg and 100mg on type 2 diabetesType 2 diabetesJPRN-UMIN000016131Osaka Saiseikai Nakatsu Hospital Division of diabetes and endocrinology600
招募中
3 期
A clinical study to evaluate the efficacy and safety of the Vamana karma followed with two Rasayanas Takradhara and Rasaoushadi in treatment of psoriasis.CTRI/2016/02/006631Central council for Research in Ayurvedic sciences CCRAS110
招募中
2 期
The study of clinical effectiveness and safety of a combination of 0.4% minoxidil and 0.05% retinaldehyde nanoparticles solution for treatment of androgenetic alopeciaFemale pattern hair lossTopical nanominoxidilAndrogenetic AlopeciaTopical retinaldehyde nanoparticlesAndrogenetic alopeciaTCTR20201104003ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital30
进行中（未招募）
Unknown
Safety and effectiveness clinical evaluation of injectable medical device Hydragel A1 in the skin quality improvementPatient seeking aesthetic treatment of the facial skin quality such as skin elasticity or firmness and facial skin radianceISRCTN10640292ouna Aesthetics40